高雄醫學大學圖書館 |

Executive Summary: Clinical Practice Guideline Clinical Practice Guideline for Lifestyle Management of Clients on Second Generation Antipsychotic Medications /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Executive Summary: Clinical Practice Guideline Clinical Practice Guideline for Lifestyle Management of Clients on Second Generation Antipsychotic Medications // Althea Andrade.
Author:	Andrade, Althea,
Description:	1 electronic resource (24 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 86-07, Section: B.
基督教聖經之智慧書導讀 :	Second-generation antipsychotics (SGAs) are a category of medications principally employed for the treatment of certain mental illnesses. One major downside of the medications is their tendency to induce weight gain, which can result in negative metabolic consequences and raise the likelihood of cardiovascular disease. The clinic setting was focused on the mental health component for the patients on SGAs, and there was little time and ability to address physical health needs, such as weight gain, nutrition, and exercise, which led to comorbidities and possible exacerbation of the mental health issues. Therefore, the purpose of this doctor of nursing practice (DNP) project was to develop and evaluate a clinical practice guideline (CPG) for lifestyle management of clients on SGAs. The project questions were two-fold. The first question was: Will the evidence-based literature support the CPG? The second question was relative to the guideline being evaluated by an expert panel using the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument: Will the clinical practice patient education guidelines (CPPEG) meet the AGREE threshold of 7 (100%)? The CPPEG did not reach a perfect score of 7, but did earn 6.66 (94%), which is within the acceptable range. Five end users/stakeholders evaluated and unanimously agreed to support the implementation of the CPPEG in the clinic. The CPPEG will guide the interdisciplinary team in the promotion of weight management in tandem with mental health services for clinic patients on SGAs. The guideline is inclusive of all communities, which will result in positive social change as patients on SGAs experience decreased stigmatization relative to being overweight and recognize the benefits from achieving optimal physical health, thus improving the human condition.
Contained By:	Dissertations Abstracts International86-07B.
Subject:	Clinical psychology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31769238
ISBN:	9798302150172

Executive Summary: Clinical Practice Guideline Clinical Practice Guideline for Lifestyle Management of Clients on Second Generation Antipsychotic Medications /
Andrade, Althea,

Executive Summary: Clinical Practice Guideline Clinical Practice Guideline for Lifestyle Management of Clients on Second Generation Antipsychotic Medications /Althea Andrade. - 1 electronic resource (24 pages)

Source: Dissertations Abstracts International, Volume: 86-07, Section: B.

Second-generation antipsychotics (SGAs) are a category of medications principally employed for the treatment of certain mental illnesses. One major downside of the medications is their tendency to induce weight gain, which can result in negative metabolic consequences and raise the likelihood of cardiovascular disease. The clinic setting was focused on the mental health component for the patients on SGAs, and there was little time and ability to address physical health needs, such as weight gain, nutrition, and exercise, which led to comorbidities and possible exacerbation of the mental health issues. Therefore, the purpose of this doctor of nursing practice (DNP) project was to develop and evaluate a clinical practice guideline (CPG) for lifestyle management of clients on SGAs. The project questions were two-fold. The first question was: Will the evidence-based literature support the CPG? The second question was relative to the guideline being evaluated by an expert panel using the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument: Will the clinical practice patient education guidelines (CPPEG) meet the AGREE threshold of 7 (100%)? The CPPEG did not reach a perfect score of 7, but did earn 6.66 (94%), which is within the acceptable range. Five end users/stakeholders evaluated and unanimously agreed to support the implementation of the CPPEG in the clinic. The CPPEG will guide the interdisciplinary team in the promotion of weight management in tandem with mental health services for clinic patients on SGAs. The guideline is inclusive of all communities, which will result in positive social change as patients on SGAs experience decreased stigmatization relative to being overweight and recognize the benefits from achieving optimal physical health, thus improving the human condition.

English

ISBN: 9798302150172Subjects--Topical Terms:

261137
Clinical psychology.
Subjects--Index Terms:

Clinical practice guideline

Executive Summary: Clinical Practice Guideline Clinical Practice Guideline for Lifestyle Management of Clients on Second Generation Antipsychotic Medications /
LDR:03392nam a22004453i 4500 001 391477
005 20251124054803.5
006 m o d
007 cr|nu||||||||
008 251208s2025 miu||||||m |||||||eng d
020 $a 9798302150172
035 $a (MiAaPQD)AAI31769238
035 $a AAI31769238
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Andrade, Althea, $e author. $3 524016
245 1 0 $a Executive Summary: Clinical Practice Guideline Clinical Practice Guideline for Lifestyle Management of Clients on Second Generation Antipsychotic Medications / $c Althea Andrade.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (24 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-07, Section: B.
500 $a Advisors: Moon, Joan Committee members: Everett, Janine.
502 $b D.N.P. $c Walden University $d 2025.
520 $a Second-generation antipsychotics (SGAs) are a category of medications principally employed for the treatment of certain mental illnesses. One major downside of the medications is their tendency to induce weight gain, which can result in negative metabolic consequences and raise the likelihood of cardiovascular disease. The clinic setting was focused on the mental health component for the patients on SGAs, and there was little time and ability to address physical health needs, such as weight gain, nutrition, and exercise, which led to comorbidities and possible exacerbation of the mental health issues. Therefore, the purpose of this doctor of nursing practice (DNP) project was to develop and evaluate a clinical practice guideline (CPG) for lifestyle management of clients on SGAs. The project questions were two-fold. The first question was: Will the evidence-based literature support the CPG? The second question was relative to the guideline being evaluated by an expert panel using the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument: Will the clinical practice patient education guidelines (CPPEG) meet the AGREE threshold of 7 (100%)? The CPPEG did not reach a perfect score of 7, but did earn 6.66 (94%), which is within the acceptable range. Five end users/stakeholders evaluated and unanimously agreed to support the implementation of the CPPEG in the clinic. The CPPEG will guide the interdisciplinary team in the promotion of weight management in tandem with mental health services for clinic patients on SGAs. The guideline is inclusive of all communities, which will result in positive social change as patients on SGAs experience decreased stigmatization relative to being overweight and recognize the benefits from achieving optimal physical health, thus improving the human condition.
546 $a English
590 $a School code: 0543
650 4 $2 96060 $a Clinical psychology. $3 261137
650 4 $2 96060 $a Mental health. $3 268440
650 4 $2 96060 $a Nursing. $3 186574
653 $a Clinical practice guideline
653 $a Lifestyle management
653 $a Mental illness
653 $a Second-generation antipsychotics
653 $a Weight gain
690 $a 0569
690 $a 0347
690 $a 0622
690 $a 0769
710 2 $a Walden University. $b Nursing. $e degree granting institution. $3 523990
720 1 $a Moon, Joan $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-07B.
790 $a 0543
791 $a D.N.P.
792 $a 2025
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31769238